Illumina Q2 revenue $1.16B (+9.5% YoY), raises FY2026 guidance on strong NovaSeq X demand

ILLUMINA, INC.

Revenue $1.16B, up 9.5% YoY; organic growth 8.1% ex-currency, acquisitions, and China.
GAAP diluted EPS $1.35, non-GAAP $1.31; GAAP operating margin 21.1%, non-GAAP 22.5%.
FY2026 guidance raised: revenue $4.60-$4.64B, non-GAAP EPS $5.30-$5.40 (prior $5.15-$5.30).
Free cash flow $162M; cash and short-term investments $1.17B at quarter end.
CEO cites strong momentum; ROW organic growth guidance raised to >5% from 2%-4%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.